CLINICAL_TRIALS
trial_result
· 2011-04-20
Clinical Trial Update: Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I [Phase 3]
Summary
Phase 3 trial evaluating zoledronic acid in patients with Stage I multiple myeloma was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Myeloma Stage I | Phase 3 | Status: TERMINATED | Results posted: 2011-04-20